|
ITCH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.64589999979748E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.05829999999629E-05 |
| Normal-vs-Stage2 |
3.922300E-03 |
| Normal-vs-Stage3 |
4.35599999959457E-07 |
| Normal-vs-Stage4 |
3.33399999996598E-06 |
| Stage1-vs-Stage2 |
6.706800E-01 |
| Stage1-vs-Stage3 |
1.461800E-01 |
| Stage1-vs-Stage4 |
1.654810E-01 |
| Stage2-vs-Stage3 |
1.687190E-01 |
| Stage2-vs-Stage4 |
1.556010E-01 |
| Stage3-vs-Stage4 |
7.838600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.88120000033499E-07 |
| Normal-vs-AfricanAmerican |
2.970500E-02 |
| Normal-vs-Asian |
1.96202999999118E-05 |
| Caucasian-vs-AfricanAmerican |
3.026200E-01 |
| Caucasian-vs-Asian |
5.138600E-01 |
| AfricanAmerican-vs-Asian |
1.652550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57834999999773E-05 |
| Normal-vs-Female |
1.70219999995336E-06 |
| Male-vs-Female |
6.815800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.562100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.07139999983019E-07 |
| Normal-vs-Age(61-80Yrs) |
1.85950999999074E-05 |
| Normal-vs-Age(81-100Yrs) |
1.759850E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.384400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.529000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.914000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.024400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.671000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.699000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.635800E-01 |
| Classical-VS-Follicular |
4.832200E-01 |
| Classical-VS-Other |
2.607200E-01 |
| Classical-VS-Normal |
2.24919999999296E-05 |
| Tall-VS-Follicular |
5.898000E-01 |
| Tall-VS-Other |
5.721000E-01 |
| Tall-VS-Normal |
2.028200E-04 |
| Follicular-VS-Other |
4.432400E-01 |
| Follicular-VS-Normal |
1.976410E-04 |
| Other-VS-Normal |
7.504200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.76179999945259E-07 |
| Normal-vs-N1 |
7.28790000015245E-07 |
| N0-vs-N1 |
2.228600E-01 |
|
|
